Literature DB >> 18395963

Chronic pelvic pain and lower urinary tract symptoms in both sexes: analysis of 2749 participants of an urban health screening project.

Martin Marszalek1, Clemens Wehrberger, Christian Temml, Anton Ponholzer, Ingrid Berger, Stephan Madersbacher.   

Abstract

BACKGROUND: Recent studies question the role of the prostate as the key factor in the pathogenesis of chronic pelvic pain syndrome (CPPS).
OBJECTIVE: To compare symptoms related to CPPS and lower urinary tract symptoms (LUTS) in both sexes. DESIGN, SETTING, AND PARTICIPANTS: Participants of a voluntary health examination in Vienna. INTERVENTION AND MEASUREMENTS: All participants completed a detailed questionnaire containing the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), with the female homolog of each male anatomical term use on questionnaires for female participants, the International Prostate Symptom Score (IPSS), and additional questions on pelvic pain. Furthermore, all participants underwent a detailed health investigation performed by a general practitioner. RESULTS AND LIMITATIONS: The study cohort comprised 1768 men and 981 women. The mean NIH-CPSI was 7.2+/-0.1 in women and 3.8+/-0.2 in men (p<0.001). In subject up to the age of 70 yr, the NIH-CPSI was higher in women (p<0.001). The NIH-CPSI increased with age in men (p<0.001), yet not in women (p=0.4). The prevalence of symptoms suggestive of CPPS in this selected population was 5.7% in women and 2.7% in men, and was higher in premenopausal women (p=0.03). Until the age of 50 yr, NIH-CPSI pain score in women exceeded that of men (p<0.001). The mean IPSS was higher in women (p<0.001). Storage symptoms were higher in women up to 60 yr, and voiding symptoms were higher in men above 60 yr. In men and women with symptoms suggestive of CPPS, the mean IPSS was significantly higher compared with those without CPPS symptoms (p<0.001). Limitations of our study are (1) that a urological evaluation was not performed and (2) that the questionnaire was not formerly validated for females.
CONCLUSION: The preponderance of CPPS in females raises questions about the etiological role of the prostate in all cases with chronic pelvic pain and suggests that other pathomechanisms are likely to be involved.

Entities:  

Mesh:

Year:  2008        PMID: 18395963     DOI: 10.1016/j.eururo.2008.03.073

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  17 in total

Review 1.  An overview of prostate diseases and their characteristics specific to Asian men.

Authors:  Shu-Jie Xia; Di Cui; Qi Jiang
Journal:  Asian J Androl       Date:  2012-02-06       Impact factor: 3.285

2.  Histopathological classification criteria of rat model of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Xianjin Wang; Shan Zhong; Tianyuan Xu; Leilei Xia; Xiaohua Zhang; Zhaowei Zhu; Minguang Zhang; Zhoujun Shen
Journal:  Int Urol Nephrol       Date:  2014-11-20       Impact factor: 2.370

3.  The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study.

Authors:  Anne M Suskind; Sandra H Berry; Brett A Ewing; Marc N Elliott; Marika J Suttorp; J Quentin Clemens
Journal:  J Urol       Date:  2012-11-16       Impact factor: 7.450

4.  Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results From the Health Professionals Follow-up Study.

Authors:  Jiachen Zhou; Karl T Kelsey; Scott Smith; Edward Giovannucci; Dominique S Michaud
Journal:  Urology       Date:  2015-04-08       Impact factor: 2.649

5.  [Prevalence and predictors of urogenital pain in men. Results from a survey of a representative German population sample].

Authors:  W Häuser; G Schmutzer; A Hinz; E Brähler
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

6.  Outcomes and clinical predictors of extracorporeal shock wave therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled clinical trial.

Authors:  Ahmed M Sakr; Amr M Fawzi; Mostafa Kamel; Maged M Ali
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-10-11       Impact factor: 5.554

7.  [Chronic pelvic pain syndrome: neurostimulation, neuromodulation and acupuncture].

Authors:  M Walter; U Sammer; T M Kessler
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

8.  The X-Y factor: Females and males with urological chronic pelvic pain syndrome present distinct clinical phenotypes.

Authors:  Gregory W Hosier; R Christopher Doiron; Victoria Tolls; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

9.  Altered resting state neuromotor connectivity in men with chronic prostatitis/chronic pelvic pain syndrome: A MAPP: Research Network Neuroimaging Study.

Authors:  Jason J Kutch; Moheb S Yani; Skulpan Asavasopon; Daniel J Kirages; Manku Rana; Louise Cosand; Jennifer S Labus; Lisa A Kilpatrick; Cody Ashe-McNalley; Melissa A Farmer; Kevin A Johnson; Timothy J Ness; Georg Deutsch; Richard E Harris; A Vania Apkarian; Daniel J Clauw; Sean C Mackey; Chris Mullins; Emeran A Mayer
Journal:  Neuroimage Clin       Date:  2015-06-05       Impact factor: 4.881

10.  Antidepressant drugs for chronic urological pelvic pain: an evidence-based review.

Authors:  Christos Papandreou; Petros Skapinakis; Dimitrios Giannakis; Nikolaos Sofikitis; Venetsanos Mavreas
Journal:  Adv Urol       Date:  2010-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.